Tefinostat Uses, Dosage, Side Effects and more
Tefinostat is under investigation in clinical trial NCT02759601 (Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)).
| Attribute | Details |
|---|---|
| Trade Name | Tefinostat |
| Generic | Tefinostat |
| Tefinostat Other Names | Tefinostat |
| Type | |
| Formula | C28H37N3O5 |
| Weight | Average: 495.62 Monoisotopic: 495.273321303 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Innovators Monograph
Search Medicines
